Growing Trend of Drug Recalls for NDSRIs
Adding to the number of recalls during 2024 for NDSRIs, Ascend (Alkem) is recalling the
Discussion forum for Pharma Quality events, Regulatory Actions
Warning letters, 483s, Recalls, Import Alerts, Audit observations
